GLP-1 receptor agonistsincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)commonly affect bowel movements, though responses vary widely among patients
Timing Baseline Marker Lipid panel Why it matters Tracks cardiometabolic changes during recomposition and weight-loss phases
The number on the scale doesnt tell the full story, Angadi says
This includes cellular health markers, inflammatory markers, metabolic panels, and other relevant biomarkers to ensure safety and track therapeutic response
outcomes firstALWAYS Explore the inspiring journeys of our patients, who have transformed their health and well-being through Nuforms personalized care